Skip to main content
Back to news
Markets

Goldman Sachs Highlights Big Pharma Interest in China Biotech Sector

(45 days ago) · 1 source · Summarized by CryptoBipto

Goldman Sachs has indicated that major pharmaceutical companies are increasingly looking to China's biotech sector for acquisition and partnership opportunities. The report suggests growing interest from global pharma firms in Chinese biotech assets.

WHY IT MATTERS

This story is not directly related to cryptocurrency or blockchain technology.

Read the full analysis with a CryptoBipto membership

Members read why every story matters and the full analysis behind it.

SOURCES

  • beincrypto.com

RELATED

Traditional FinanceBiotechGoldman Sachs